ライフサイエンス, 消化器内科学

Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial.
Toru Nakamura; Atsutaka Masuda; Makoto Kako; Hirayuki Enomoto; Masaki Kaibori; Yasuyuki Fujita; Kyoko Tanizawa; Tetsuya Ioji; Yoshihiro Fujimori; Kei Fukami; Takuma Hazama; Hideki Iwamoto; Yasukazu Kako; Kaoru Kobayashi; Hironori Koga; Koji Nagafuji; Takayasu Ohtake; Hiroyuki Suzuki; Tomoyuki Takashima; Toshitaka Tsukiyama; Haruki Uojima; Kenichi Yamahara; Koichiro Yamakado; Hidekazu Yamamoto; Kazunori Yoh; Satoshi Yoshihara; Atsuhiko Kawamoto; Shuhei Nishiguchi; Shuzo Kobayashi; Takuji Torimura; Takumi Kawaguchi
Regenerative therapy, 2024年12月

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real-world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Hiroki Nishikawa; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Yuichi Koshiyama; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Hideko Ohama; Fujimasa Tada; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Takashi Nishimura; Michitaka Imai; Hisashi Kosaka; Atsushi Naganuma; Tomomitsu Matono; Tomoko Aoki; Hidekatsu Kuroda; Yutaka Yata; Yohei Koizumi; Shinichiro Nakamura; Hirayuki Enomoto; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo
Alimentary pharmacology & therapeutics, 2024年05月

Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.
Natsuko Kobayashi; Toshifumi Tada; Takashi Nishimura; Tomomitsu Matono; Yukihisa Yuri; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Shinya Fukunishi; Mariko Hashimoto; Mitsumasa Ohyanagi; Hirayuki Enomoto; Hiroko Iijima
Hepatology research : the official journal of the Japan Society of Hepatology, 2024年05月

Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.
Hirayuki Enomoto; Norio Akuta; Hayato Hikita; Goki Suda; Jun Inoue; Nobuharu Tamaki; Kiyoaki Ito; Takemi Akahane; Tomokazu Kawaoka; Asahiro Morishita; Eiichi Ogawa; Ryosuke Tateishi; Hitoshi Yoshiji
Hepatology research : the official journal of the Japan Society of Hepatology, 2024年04月

VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response.
Tomomitsu Matono; Toshifumi Tada; Takashi Nishimura; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Hideyuki Shiomi; Hirayuki Enomoto; Hiroko Iijima
Journal of medical ultrasonics (2001), 2024年04月

Recanalization using a novel drill-shaped dilator for a severe pancreatic duct stricture and impacted pancreatic duct stone.
Hideyuki Shiomi; Ryota Nakano; Shogo Ota; Takashi Nishimura; Hirayuki Enomoto; Hiroko Iijima
Endoscopy, 2023年12月

A Low Geriatric Nutritional Risk Index Is Associated with Low Muscle Volume and a Poor Prognosis among Cirrhotic Patients.
Hirayuki Enomoto; Yukihisa Yuri; Takashi Nishimura; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Mamiko Okamoto; Kohei Yoshihara; Ryota Yoshioka; Shoki Kawata; Yuta Kawase; Ryota Nakano; Hideyuki Shiomi; Shinya Fukunishi; Shinichiro Shinzaki; Hiroko Iijima
Medicina (Kaunas, Lithuania), 2023年11月

Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
Chuan Liu; Zhujun Cao; Huadong Yan; Yu Jun Wong; Qing Xie; Masashi Hirooka; Hirayuki Enomoto; Tae Hyung Kim; Amr Shaaban Hanafy; Yanna Liu; Yifei Huang; Xiaoguo Li; Ning Kang; Yohei Koizumi; Yoichi Hiasa; Takashi Nishimura; Hiroko Iijima; Young Kul Jung; Hyung Joon Yim; Ying Guo; Linpeng Zhang; Jianzhong Ma; Manoj Kumar; Ankur Jindal; Kok Ban Teh; Shiv Kumar Sarin; Xiaolong Qi
The American journal of gastroenterology, 2023年07月

A case of delayed pancreatic fistula after covered self-expandable metallic stent deployment for pancreatic head cancer.
Shogo Ota; Hideyuki Shiomi; Ryota Nakano; Takashi Nishimura; Hirayuki Enomoto; Hiroko Iijima
Clinical journal of gastroenterology, 2023年04月

Metastasis of Hepatocellular Carcinoma in the Pouch of Douglas Successfully Treated by Radiation Therapy: A Case Report.
Hirayuki Enomoto; Masayuki Fujiwara; Hiroshi Kono; Yasukazu Kako; Motonori Takahagi; Junichi Taniguchi; Eri Ishikawa; Naoto Ikeda; Tomoyuki Takashima; Yukihisa Yuri; Nobuhiro Aizawa; Mamiko Okamoto; Kohei Yoshihara; Ryota Yoshioka; Shoki Kawata; Shogo Ota; Ryota Nakano; Hideyuki Shiomi; Takashi Nishimura; Seiichi Hirota; Koichiro Yamakado; Hiroko Iijima
Life (Basel, Switzerland), 2023年01月

Association of PNPLA3 SNP With the Development of HBV-related Hepatocellular Carcinoma.
Hirayuki Enomoto; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Yukihisa Yuri; Mamiko Okamoto; Ryota Yoshioka; Shoki Kawata; Kohei Yoshihara; Shogo Ota; Ryota Nakano; Hideyuki Shiomi; Takashi Nishimura; Hiroko Iijima
In vivo (Athens, Greece), 2023年

Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells.
Hirayuki Enomoto; Takashi Nishimura; Shinya Fukunushi; Hideyuki Shiomi; Hiroko Iijima
In vivo (Athens, Greece), 2023年

Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis.
Minako Yuri; Takashi Nishimura; Toshifumi Tada; Masahiro Yoshida; Aoi Fujiwara; Shoki Kawata; Kohei Yoshihara; Ryota Yoshioka; Shogo Ota; Ryota Nakano; Yukihisa Yuri; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Hideyuki Shiomi; Yoshi-Hiro Ide; Hirayuki Enomoto; Fujimoto Yasuhiro; Hirohisa Yano; Hiroko Iijima
Hepatology research : the official journal of the Japan Society of Hepatology, 2022年12月

ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study.
Chuan Liu; Jia Li; Yu Jun Wong; Qing Xie; Masashi Hirooka; Hirayuki Enomoto; Tae Hyung Kim; Amr Shaaban Hanafy; Ruiling He; Yohei Koizumi; Yoichi Hiasa; Takashi Nishimura; Hiroko Iijima; Young Kul Jung; Hyung Joon Yim; Jianzhong Ma; Qing-Lei Zeng; Shiv Kumar Sarin; Xiaolong Qi
Hepatology international, 2022年10月

A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
Chuan Liu; Zhujun Cao; Huadong Yan; Yu Jun Wong; Qing Xie; Masashi Hirooka; Hirayuki Enomoto; Tae Hyung Kim; Amr Shaaban Hanafy; Yanna Liu; Yifei Huang; Xiaoguo Li; Ning Kang; Yohei Koizumi; Yoichi Hiasa; Takashi Nishimura; Hiroko Iijima; Young Kul Jung; Hyung Joon Yim; Ying Guo; Linpeng Zhang; Jianzhong Ma; Manoj Kumar; Ankur Jindal; Kok Ban Teh; Shiv Kumar Sarin; Xiaolong Qi
The American journal of gastroenterology, 2022年10月

No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.
Masaaki Korenaga; Kazumoto Murata; Namiki Izumi; Nobuharu Tamaki; Osamu Yokosuka; Tetsuo Takehara; Naoya Sakamoto; Goki Suda; Shuhei Nishiguchi; Hirayuki Enomoto; Fusao Ikeda; Mikio Yanase; Hidenori Toyoda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Kazumi Yamasaki; Tatsuya Ide; Nobuo Toda; Tatsuo Kanda; Kazushige Nirei; Yoshiyuki Ueno; Hiroaki Haga; Yoichi Nishigaki; Kunio Nakane; Masao Omata; Hitoshi Mochizuki; Yoshihiko Aoki; Masatoshi Imamura; Tatsuya Kanto; Masashi Mizokami
Global health & medicine, 2022年08月

Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era.
Tatsuo Kanda; Reina Sasaki-Tanaka; Tomotaka Ishii; Hayato Abe; Masahiro Ogawa; Hirayuki Enomoto
Journal of clinical medicine, 2022年07月

Clinical Characteristics of ICI-Related Pancreatitis and Cholangitis Including Radiographic and Endoscopic Findings.
Ryota Nakano; Hideyuki Shiomi; Aoi Fujiwara; Kohei Yoshihara; Ryota Yoshioka; Shoki Kawata; Shogo Ota; Yukihisa Yuri; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Takashi Nishimura; Hirayuki Enomoto; Hiroko Iijima
Healthcare (Basel, Switzerland), 2022年04月

Multiple Inflammatory Pseudotumors of the Liver Demonstrating Spontaneous Regression: A Case Report.
Noriko Ishii-Kitano; Hirayuki Enomoto; Takashi Nishimura; Nobuhiro Aizawa; Yoko Shibata; Akiko Higashiura; Tomoyuki Takashima; Naoto Ikeda; Yukihisa Yuri; Aoi Fujiwara; Kohei Yoshihara; Ryota Yoshioka; Shoki Kawata; Shogo Ota; Ryota Nakano; Hideyuki Shiomi; Seiichi Hirota; Tsutomu Kumabe; Osamu Nakashima; Hiroko Iijima
Life (Basel, Switzerland), 2022年01月

Risk stratification of decompensation using liver stiffness and platelet counts in compensated advanced chronic liver disease (CHESS2102).
Yanna Liu; Chuan Liu; Jia Li; Tae Hyung Kim; Hirayuki Enomoto; Xiaolong Qi
Journal of hepatology, 2022年01月

Possible Alterations in Appetite-related Molecules After the Elimination of Hepatitis C Virus.
Yoshihiro Shimono; Hirayuki Enomoto; Nobuhiro Aizawa; Tomoyuki Takashima; Naoto Ikeda; Yukihisa Yuri; Aoi Fujiwara; Kohei Yoshihara; Ryota Yoshioka; Shoki Kawata; Shogo Ota; Ryota Nakano; Hideyuki Shiomi; Takashi Nishimura; Hiroko Iijima
In vivo (Athens, Greece), 2022年

Modification of the ALBI-PLT Score for the Prediction of High-risk Varices.
Minako Inoue-Yuri; Hirayuki Enomoto; Ichiro Wakabayashi; Yukihisa Yuri; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Aoi Fujiwara; Ryota Yoshioka; Shoki Kawata; Kohei Yoshihara; Shogo Ota; Ryota Nakano; Hideyuki Shiomi; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2022年

超音波エラストグラフィによる肝硬度高値が診断の端緒となった乳癌びまん性肝転移の1例
東浦 晶子; 西村 貴士; 吉田 昌弘; 西村 純子; 橋本 眞里子; 柴田 陽子; 藤原 葵; 由利 幸久; 高嶋 智之; 會澤 信弘; 池田 直人; 榎本 平之; 今村 美智子; 三好 康雄; 廣田 誠一; 飯島 尋子
肝臓, 2021年10月

Association of liver stiffness and steatosis with hepatocellular carcinoma development in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
Toshifumi Tada; Takashi Nishimura; Tomomitsu Matono; Masahiro Yoshida; Minako Yuri; Aoi Fujiwara; Yukihisa Yuri; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Hirayuki Enomoto; Takashi Kumada; Hiroko Iijima
Hepatology research : the official journal of the Japan Society of Hepatology, 2021年08月

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Diagnostics (Basel, Switzerland), 2021年07月

Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation.
Akihiro Tamori; Kiminori Kimura; Kiyohide Kioka; Hirayuki Enomoto; Naoshi Odagiri; Ritsuzo Kozuka; Sawako Uchida-Kobayashi; Masaru Enomoto; Norifumi Kawada; Masashi Mizokami
Journal of medical virology, 2021年06月

Clinical impact of the finger-circle test in patients with liver diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Hepatology research : the official journal of the Japan Society of Hepatology, 2021年05月

A New Ultrasonographic "Fluttering Sign" for Hepatic Hemangioma.
Natsuko Kobayashi; Hiroko Iijima; Toshifumi Tada; Yoko Shibata; Takashi Nishimura; Takashi Kumada; Mariko Hashimoto; Akiko Higashiura; Masahiro Yoshida; Junko Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroki Nishikawa; Yoshinori Iwata; Hirayuki Enomoto; Seiichi Hirota; Etsuro Hatano
Ultrasound in medicine & biology, 2021年04月

Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients.
Chikage Nakano; Takashi Nishimura; Toshifumi Tada; Masahiro Yoshida; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Hiroki Nishikawa; Hirayuki Enomoto; Etsuro Hatano; Hirohisa Yano; Seiichi Hirota; Hiroyuki Hachiya; Hiroko Iijima
Hepatology research : the official journal of the Japan Society of Hepatology, 2021年04月

Reply to the letter by Huo et al. regarding our manuscript "The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan".
Hirayuki Enomoto; Shuhei Nishiguchi
Journal of gastroenterology, 2021年04月

Reduced grip strength is associated with progression of depressive status in chronic liver diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Annals of palliative medicine, 2021年04月

Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Annals of translational medicine, 2021年04月

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.
Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
International journal of molecular sciences, 2021年02月

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
Hirayuki Enomoto; Yoshiyuki Ueno; Yoichi Hiasa; Hiroki Nishikawa; Shuhei Hige; Yasuhiro Takikawa; Makiko Taniai; Toru Ishikawa; Kohichiroh Yasui; Akinobu Takaki; Koichi Takaguchi; Akio Ido; Masayuki Kurosaki; Tatsuya Kanto; Shuhei Nishiguchi
Journal of gastroenterology, 2021年02月

Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2021年

Association of the Modified ALBI Grade With Endoscopic Findings of Gastroesophageal Varices.
Yuho Miyamoto; Hirayuki Enomoto; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2021年

Factors Associated With Longitudinal QOL Change in Patients With Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2021年

Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B.
Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Yasuhito Tanaka; Noboru Shinkai; Chiaki Okuse; Jong-Hon Kang; Takeshi Matsui; Shiho Miyase; Hiroshi Yatsuhashi; Shinya Nagaoka; Tatsuo Kanda; Masaru Enomoto; Ryoko Yamada; Naoki Hiramatsu; Satoru Saito; Koichi Takaguchi; Kiyoaki Ito; Tsutomu Masaki; Daisuke Morihara; Masataka Tsuge; Kazuaki Chayama; Fusao Ikeda; Tatehiro Kagawa; Yasuteru Kondo; Kazumoto Murata; Eiji Tanaka
Journal of gastroenterology, 2020年10月

Frailty and Sleep Disorder in Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Life (Basel, Switzerland), 2020年08月

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.
Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
International journal of molecular sciences, 2020年07月

Close Correlation between Frailty and Depressive State in Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Medicina (Kaunas, Lithuania), 2020年06月

Anthropometric Measurements and Frailty in Patients with Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Naoto Ikeda; Nobuhiro Aizawa; Takashi Koriyama; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Diagnostics (Basel, Switzerland), 2020年06月

Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies.
Hirayuki Enomoto; Hideji Nakamura; Hiroki Nishikawa; Shuhei Nishiguchi; Hiroko Iijima
International journal of molecular sciences, 2020年06月

Health-Related Quality of Life and Frailty in Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Life (Basel, Switzerland), 2020年05月

Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal of clinical medicine, 2020年05月

Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients.
Hirayuki Enomoto; Nobuhiro Aizawa; Kunihiro Hasegawa; Naoto Ikeda; Yoshiyuki Sakai; Kazunori Yoh; Ryo Takata; Yukihisa Yuri; Kyohei Kishino; Yoshihiro Shimono; Noriko Ishii; Tomoyuki Takashima; Takashi Nishimura; Hiroki Nishikawa; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
International journal of molecular sciences, 2020年04月

Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Naoto Ikeda; Nobuhiro Aizawa; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Diagnostics (Basel, Switzerland), 2020年04月

Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.
Hirayuki Enomoto; Yoshiyuki Ueno; Yoichi Hiasa; Hiroki Nishikawa; Shuhei Hige; Yasuhiro Takikawa; Makiko Taniai; Toru Ishikawa; Kohichiroh Yasui; Akinobu Takaki; Koichi Takaguchi; Akio Ido; Masayuki Kurosaki; Tatsuya Kanto; Shuhei Nishiguchi
Journal of gastroenterology, 2020年03月

Serum Zinc Level Grading System: A Useful Model for Composite Hepatic Events in Hepatitis C Virus-Associated Liver Cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2020年02月

Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.
Hiroki Nishikawa; Ryo Takata; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2020年01月

Walking Speed: Japanese Data in Chronic Liver Diseases.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2020年01月

Serum zinc concentration and quality of life in chronic liver diseases.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2020年01月

Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy.
Noriko Ishii; Hiroki Nishikawa; Yoshinori Iwata; Hirayuki Enomoto; Hironori Tanaka; Nobuyuki Katakami; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of Cancer, 2020年

The Anthropometric Assessment With the Bioimpedance Method Is Associated With the Prognosis of Cirrhotic Patients.
Ei-Ichiro Moriwaki; Hirayuki Enomoto; Masaki Saito; Naoki Hara; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
In vivo (Athens, Greece), 2020年

Arm Skeletal Muscle Mass Is Associated With the Prognosis of Patients With Cirrhosis.
Yoshihiro Shimono; Hirayuki Enomoto; Kyohei Kishino; Ei-Ichiro Moriwaki; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
In vivo (Athens, Greece), 2020年

Association of an Overhydrated State With the Liver Fibrosis and Prognosis of Cirrhotic Patients.
Kyohei Kishino; Hirayuki Enomoto; Yoshihiro Shimono; Ei-Ichiro Moriwaki; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
In vivo (Athens, Greece), 2020年

Hepatocellular Carcinoma-associated microRNAs Induced by Hepatoma-derived Growth Factor Stimulation.
Hirayuki Enomoto; Hideji Nakamura; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2020年

Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2020年

Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
In vivo (Athens, Greece), 2020年

Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis.
Yukihisa Yuri; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年12月

Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2019年12月

Serum Zinc Level Classification System: Usefulness in Patients with Liver Cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年11月

Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.
Toshifumi Tada; Hiroko Iijima; Natsuko Kobayashi; Masahiro Yoshida; Takashi Nishimura; Takashi Kumada; Reiichiro Kondo; Hirohisa Yano; Masayoshi Kage; Chikage Nakano; Tomoko Aoki; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Yukihisa Yuri; Noriko Ishii; Kunihiro Hasegawa; Ryo Takata; Kazunori Yoh; Yoshiyuki Sakai; Hiroki Nishikawa; Yoshinori Iwata; Hirayuki Enomoto; Seiichi Hirota; Jiro Fujimoto; Shuhei Nishiguchi
Ultrasound in medicine & biology, 2019年10月

Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.
Ryo Takata; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年09月

Significant Correlation Between Grip Strength and m2bpgi in Patients with Chronic Liver Diseases.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年09月

Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases.
Takashi Nishimura; Hiroko Iijima; Hiroki Nishikawa; Reiichiro Kondo; Hirohisa Yano; Masayoshi Kage; Tomoko Aoki; Chikage Nakano; Yukihisa Yuri; Noriko Ishii; Kunihiro Hasegawa; Ryo Takata; Kazunori Yoh; Yoshiyuki Sakai; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Yoshinori Iwata; Hirayuki Enomoto; Seiichi Hirota; Jiro Fujimoto; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2019年07月

Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年06月

Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices.
Hiroko Iijima; Toshifumi Tada; Takashi Kumada; Natsuko Kobayashi; Masahiro Yoshida; Tomoko Aoki; Takashi Nishimura; Chikage Nakano; Akio Ishii; Tomoyuki Takashima; Yoshiyuki Sakai; Nobuhiro Aizawa; Hiroki Nishikawa; Naoto Ikeda; Yoshinori Iwata; Hirayuki Enomoto; Yoshi-Hiro Ide; Seiichi Hirota; Jiro Fujimoto; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2019年06月

Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年05月

Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2019年03月

Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis B.
Kunihiro Hasegawa; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kazunori Yoh; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Etsuro Hatano; Jiro Fujimoto; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2019年03月

Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2018年12月

Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine, 2018年12月

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
Kentaro Matsuura; Nobuhiro Aizawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hidenori Toyoda; Takashi Kumada; Etsuko Iio; Kyoko Ito; Shintaro Ogawa; Masanori Isogawa; Harvey J Alter; Yasuhito Tanaka
Open forum infectious diseases, 2018年11月

Association of the Body Mass Index with the Presence of Gastroesophageal Varices in Compensated Cirrhotic Patients with Hepatitis C Viral Infection.
Hirayuki Enomoto; Nobuhiro Aizawa; Naoto Ikeda; Yoshiyuki Sakai; Ryo Takata; Kunihiro Hasegawa; Yuho Miyamoto; Minako Inoue; Takashi Nishimura; Chikage Nakano; Noriko Ishii; Yukihisa Yuri; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Hiroki Nishikawa; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Annals of clinical and laboratory science, 2018年11月

The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Noriko Ishii; Yoshinori Iwata; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Kunihiro Hasegawa; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Nutrients, 2018年08月

Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Noriko Ishii; Yoshinori Iwata; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Kunihiro Hasegawa; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Nutrients, 2018年08月

Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction.
Hirayuki Enomoto; Shin-Ichi Inoue; Akio Matsuhisa; Yoshinori Iwata; Nobuhiro Aizawa; Yoshiyuki Sakai; Ryo Takata; Naoto Ikeda; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Akio Ishii; Tomoyuki Takashima; Hiroki Nishikawa; Hiroko Iijima; Shuhei Nishiguchi
Molecular medicine reports, 2018年08月

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.
Namiki Izumi; Tetsuo Takehara; Kazuaki Chayama; Hiroshi Yatsuhashi; Koichi Takaguchi; Tatsuya Ide; Masayuki Kurosaki; Yoshiyuki Ueno; Hidenori Toyoda; Satoru Kakizaki; Yasuhito Tanaka; Yoshiiku Kawakami; Hirayuki Enomoto; Fusao Ikeda; Deyuan Jiang; Shampa De-Oertel; Brian L McNabb; Gregory Camus; Luisa M Stamm; Diana M Brainard; John G McHutchison; Satoshi Mochida; Masashi Mizokami
Hepatology international, 2018年07月

Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B.
Masaru Enomoto; Shuhei Nishiguchi; Akihiro Tamori; Ritsuzo Kozuka; Hideki Fujii; Sawako Uchida-Kobayashi; Shinya Fukunishi; Yasuhiro Tsuda; Kazuhide Higuchi; Masaki Saito; Hirayuki Enomoto; Norifumi Kawada
Hepatology research : the official journal of the Japan Society of Hepatology, 2018年05月

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Jong-Hon Kang; Yasuhito Tanaka; Noboru Shinkai; Masayuki Kurosaki; Masaru Enomoto; Tatsuo Kanda; Osamu Yokosuka; Hiroshi Yatsuhashi; Shinya Nagaoka; Chiaki Okuse; Tatehiro Kagawa; Tetsuya Mine; Koichi Takaguchi; Satoru Saito; Keisuke Hino; Fusao Ikeda; Shotaro Sakisaka; Daisuke Morihara; Shiho Miyase; Masataka Tsuge; Kazuaki Chayama; Naoki Hiramatsu; Yoshiyuki Suzuki; Kazumoto Murata; Eiji Tanaka
Journal of gastroenterology, 2018年02月

超音波減衰法“Attenuation imaging”による新しい脂肪肝診断
飯島 尋子; 西村 貴士; 多田 俊史; 中野 智景; 青木 智子; 高嶋 智之; 池田 直人; 會澤 信弘; 西川 浩樹; 岩田 恵典; 榎本 平之; 藤元 治朗; 鹿毛 政義; 熊田 卓; 西口 修平; 矢野 博久
肝臓, 2018年

Clinical influence of exercise therapy on sarcopenia in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2018年

Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2018年

Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Noriko Ishii; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2018年

Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Noriko Ishii; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2018年

肝疾患とサルコペニア
西口 修平; 西川 浩樹; 榎本 平之
日本消化器病学会雑誌, 2018年

Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response
Natsuko Kobayashi; Hiroko Iijima; Toshifumi Tada; Takashi Kumada; Masahiro Yoshida; Tomoko Aoki; Takashi Nishimura; Chikage Nakano; Ryo Takata; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Yoshiyuki Sakai; Nobuhiro Aizawa; Hiroki Nishikawa; Naoto Ikeda; Yoshinori Iwata; Hirayuki Enomoto; Seiichi Hirota; Jiro Fujimoto; Shuhei Nishiguchi
European Journal of Gastroenterology and Hepatology, 2018年, ［査読有り］

Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal of cachexia, sarcopenia and muscle, 2017年12月

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.
Ryo Takata; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2017年12月

Development of a simple predictive model for decreased skeletal muscle mass in patients with compensated chronic liver disease.
Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Ryo Takata; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2017年11月

Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.
Noriko Ishii; Yoshinori Iwata; Hiroki Nishikawa; Hirayuki Enomoto; Nobuhiro Aizawa; Akio Ishii; Yuho Miyamoto; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Oncology letters, 2017年11月

Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Nutrients, 2017年10月

The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis.
Hirayuki Enomoto; Lihua Tao; Ryoji Eguchi; Ayuko Sato; Masao Honda; Shuichi Kaneko; Yoshinori Iwata; Hiroki Nishikawa; Hiroyasu Imanishi; Hiroko Iijima; Tohru Tsujimura; Shuhei Nishiguchi
Scientific reports, 2017年09月

Prognostic significance of low skeletal muscle mass compared with protein-energy malnutrition in liver cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Ryo Takata; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2017年09月

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.
Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Oncology letters, 2017年08月

Clinical utility of bioimpedance analysis in liver cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal of hepato-biliary-pancreatic sciences, 2017年07月

Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver Diseases.
Hiroki Nishikawa; Takashi Nishimura; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Ryo Takata; Kunihiro Hasegawa; Chikage Nakano; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Shuhei Nishiguchi; Hiroko Iijima
Nutrients, 2017年06月

Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Nutrients, 2017年06月

Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices.
Yoshiyuki Sakai; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2017年06月

Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices.
Hiroki Nishikawa; Yukihisa Yuri; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2017年05月

Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia.
Hirayuki Enomoto; Shuhei Nishiguchi
Inflammatory intestinal diseases, 2017年04月

Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C.
Hiroki Nishikawa; Ryo Takata; Hirayuki Enomoto; Kazunori Yoh; Kyohei Kishino; Yoshihiro Shimono; Yoshinori Iwata; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2017年03月

Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B.
Akio Ishii; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2017年02月

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Akio Ishii; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2017年01月

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir.
Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Journal of Cancer, 2017年

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.
Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Journal of Cancer, 2017年

Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for oesophageal varices: a study protocol for prospective interventional study.
Hiroki Nishikawa; Yoshinori Iwata; Akio Ishii; Hirayuki Enomoto; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2017年

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy.
Yukihisa Yuri; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal of Cancer, 2017年

Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: a study protocol for single-arm, prospective, interventional study.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2017年

Efficacy of capsule endoscopy in patients with cirrhosis for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities: a study protocol for prospective interventional study.
Yoshinori Iwata; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Akio Ishii; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2017年

Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
BMJ open gastroenterology, 2017年

Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases.
Tomoko Aoki; Hiroko Iijima; Toshifumi Tada; Takashi Kumada; Takashi Nishimura; Chikage Nakano; Kyohei Kishino; Yoshihiro Shimono; Kazunori Yoh; Ryo Takata; Akio Ishii; Tomoyuki Takashima; Yoshiyuki Sakai; Nobuhiro Aizawa; Hiroki Nishikawa; Naoto Ikeda; Yoshinori Iwata; Hirayuki Enomoto; Seiichi Hirota; Jiro Fujimoto; Shuhei Nishiguchi
Journal of gastroenterology, 2017年01月

Comparison of sleep disorders in chronic hepatitis C patients treated with interferon-based therapy and direct acting antivirals using actigraphy.
Kazunori Yoh; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Hisato Matsunaga; Hideji Nakamura; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2016年12月

Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients.
Tomoyuki Takashima; Hirayuki Enomoto; Yoshinori Iwata; Hiroki Nishikawa; Kazunori Yoh; Kunihiro Hasegawa; Chikage Nakano; Yukihisa Yuri; Noriko Ishii; Yuho Miyamoto; Ryo Takata; Takashi Nishimura; Akio Ishii; Yoshiyuki Sakai; Nobuhiro Aizawa; Naoto Ikeda; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine research, 2016年12月

Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.
Yoshiyuki Sakai; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Kunihiro Hasegawa; Chikage Nakano; Kyohei Kishino; Yoshihiro Shimono; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Shuhei Nishiguchi
Journal of clinical medicine research, 2016年12月

Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Kazunori Yoh; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Hideji Nakamura; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2016年11月

Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Akiio Ishii; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2016年10月

Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
Kunihiro Hasegawa; Ryo Takata; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
International journal of molecular sciences, 2016年09月

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.
Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Medicine, 2016年09月

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.
Hiroki Nishikawa; Kunihiro Hasegawa; Akio Ishii; Ryo Takata; Hirayuki Enomoto; Kazunori Yoh; Kyohei Kishino; Yoshihiro Shimono; Yoshinori Iwata; Chikage Nakano; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2016年08月

Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2016年06月

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.
Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Kyohei Kishino; Yoshihiro Shimono; Yoshiyuki Sakai; Takashi Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2016年06月

Improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment.
Hirayuki Enomoto; Hiroki Nishikawa; Naoto Ikeda; Nobuhiro Aizawa; Yoshiyuki Sakai; Kazunori Yoh; Ryo Takata; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Akio Ishii; Tomoyuki Takashima; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Hepatitis monthly, 2016年06月

Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2016年05月

Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load.
Hirayuki Enomoto; Nobuhiro Aizawa; Hiroki Nishikawa; Naoto Ikeda; Yoshiyuki Sakai; Ryo Takata; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2016年04月

B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis.
Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Akio Ishii; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2016年03月

経口薬による抗HCV治療がもたらす新時代
榎本 平之; 西口 修平
日本消化器病学会雑誌, 2016年

Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry.
Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Shuhei Nishiguchi
Medicine, 2016年01月

Corrigendum to "An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients".
Hirayuki Enomoto; Nobuhiro Aizawa; Hideji Nakamura; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoko Aoki; Yukihisa Yuri; Kazunori Yoh; Kenji Hashimoto; Akio Ishii; Tomoyuki Takashima; Kazunari Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Gastroenterology research and practice, 2016年

Basic and Clinical Advances in Chronic Liver Inflammation.
Hirayuki Enomoto; Akihiro Tamori; Hitoshi Yoshiji; Ekihiro Seki
Mediators of inflammation, 2016年

Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Hirayuki Enomoto; Hideji Nakamura; Weidong Liu; Yoshinori Iwata; Hiroki Nishikawa; Ryo Takata; Kazunori Yoh; Kunihiro Hasegawa; Akio Ishii; Tomoyuki Takashima; Yoshiyuki Sakai; Nobuhiro Aizawa; Naoto Ikeda; Hiroko Iijima; Shuhei Nishiguchi
Anticancer research, 2015年12月

Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C.
Hirayuki Enomoto; Shuhei Nishiguchi
World journal of hepatology, 2015年11月

Development of risky varices in alcoholic cirrhosis with a well-maintained nutritional status.
Hirayuki Enomoto; Yoshiyuki Sakai; Yoshinori Iwata; Ryo Takata; Nobuhiro Aizawa; Naoto Ikeda; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Hiroki Nishikawa; Hiroko Iijima; Shuhei Nishiguchi
World journal of hepatology, 2015年09月

Liver fibrosis markers of nonalcoholic steatohepatitis.
Hirayuki Enomoto; Yukihiro Bando; Hideji Nakamura; Shuhei Nishiguchi; Masafumi Koga
World journal of gastroenterology, 2015年06月

Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.
Hirayuki Enomoto; Hideji Nakamura; Weidong Liu; Shuhei Nishiguchi
International journal of molecular sciences, 2015年06月

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.
Masashi Mizokami; Osamu Yokosuka; Tetsuo Takehara; Naoya Sakamoto; Masaaki Korenaga; Hitoshi Mochizuki; Kunio Nakane; Hirayuki Enomoto; Fusao Ikeda; Mikio Yanase; Hidenori Toyoda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Tatsuya Ide; Nobuo Toda; Kazushige Nirei; Yoshiyuki Ueno; Yoichi Nishigaki; Juan Betular; Bing Gao; Akinobu Ishizaki; Masa Omote; Hongmei Mo; Kim Garrison; Phillip S Pang; Steven J Knox; William T Symonds; John G McHutchison; Namiki Izumi; Masao Omata
The Lancet. Infectious diseases, 2015年06月

[PEG-IFN/IFN monotherapy].
Hirayuki Enomoto; Shuhei Nishiguchi
Nihon rinsho. Japanese journal of clinical medicine, 2015年02月

慢性肝炎における肝線維化マーカーELFスコアの有用性
高嶋 智之; 飯島 尋子; 青木 智子; 中野 智景; 會澤 信弘; 岸野 恭平; 霜野 良弘; 長谷川 国大; 高田 亮; 楊 和典; 石井 昭生; 坂井 良行; 西村 貴士; 西川 浩樹; 岩田 恵典; 池田 直人; 榎本 平之; 廣田 誠一; 藤元 治朗; 矢野 博久; 中島 収; 鹿毛 政義; 西口 修平
肝臓, 2015年

Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.
Yoshiyuki Sakai; Yoshinori Iwata; Hirayuki Enomoto; Masaki Saito; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Hironori Tanaka; Hiroko Iijima; Shuhei Nishiguchi
Journal of gastroenterology, 2015年01月

A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients.
Hirayuki Enomoto; Nobuhiro Aizawa; Hideji Nakamura; Ryo Takata; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoko Aoki; Kunihiro Hasegawa; Kazunori Yoh; Kenji Hashimoto; Akio Ishii; Tomoyuki Takashima; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Gastroenterology research and practice, 2015年

Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy.
Hiroki Nishikawa; Hirayuki Enomoto; Akihiro Nasu; Nobuhiro Aizawa; Masaki Saito; Akihiro Tamori; Norifumi Kawada; Toru Kimura; Yukio Osaki; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2014年12月

Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro.
Chisa Kuga; Hirayuki Enomoto; Nobuhiro Aizawa; Tomoyuki Takashima; Naoto Ikeda; Akio Ishii; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Masaki Saito; Hiroko Iijma; Shuhei Nishiguchi
Biochemical and biophysical research communications, 2014年11月

Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis.
Kazunari Iwata; Hirayuki Enomoto; Shuhei Nishiguchi; Nobuhiro Aizawa; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoyuki Takashima; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Yasuhiro Tsuda; Kazuhide Higuchi
Journal of clinical biochemistry and nutrition, 2014年09月

Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count.
Naoto Ikeda; Hiroyasu Imanishi; Nobuhiro Aizawa; Hironori Tanaka; Yoshinori Iwata; Hirayuki Enomoto; Masaki Saito; Hiroko Iijima; Yuji Iimuro; Jiro Fujimoto; Satoshi Yamamoto; Shozo Hirota; Masatoshi Kudo; Shigeki Arii; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2014年08月

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
Nobuhiro Aizawa; Hirayuki Enomoto; Tomoyuki Takashima; Yoshiyuki Sakai; Kazunari Iwata; Naoto Ikeda; Hironori Tanaka; Yoshinori Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Journal of gastroenterology, 2014年08月

Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment.
Tomoyuki Takashima; Hirayuki Enomoto; Toshiaki Ninomiya; Soo Ryang Kim; Hiroaki Okushin; Masahiko Sugano; Susumu Imoto; Yoshihiko Yano; Teruji Ooka; Yasushi Seo; Hiroshi Kasugai; Akira Muramatsu; Hisato Jomura; Soji Shimomura; Michiko Shindo; Hideji Nakamura; Nobuhiro Aizawa; Yoshinori Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijma; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2014年06月

New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
Hironori Tanaka; Hiroko Iijima; Akiko Higashiura; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Yoshiyuki Sakai; Nobuhiro Aizawa; Kazunari Iwata; Naoto Ikeda; Yoshinori Iwata; Hirayuki Enomoto; Masaki Saito; Hiroyasu Imanishi; Seiichi Hirota; Jiro Fujimoto; Shuhei Nishiguchi
Journal of gastroenterology, 2014年04月

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.
Shuhei Nishiguchi; Hirayuki Enomoto; Nobuhiro Aizawa; Hiroki Nishikawa; Yukio Osaki; Yasuhiro Tsuda; Kazuhide Higuchi; Kazuichi Okazaki; Toshihito Seki; Soo Ryang Kim; Yasushi Hongo; Hisato Jyomura; Naoshi Nishida; Masatoshi Kudo
Journal of gastroenterology, 2014年03月

肝線維化診断における新しいshear wave elastographyの優越性
飯島 尋子; 吉田 昌弘; 橋本 眞里子; 中野 智景; 青木 智子; 橋本 健二; 田中 弘教; 會澤 信弘; 石井 昭生; 高嶋 智之; 坂井 良行; 岩田 恵典; 池田 直人; 榎本 平之; 斎藤 正紀; 西口 修平; 廣田 誠一; 藤元 治朗; 矢野 博久; 中島 収; 鹿毛 政義
肝臓, 2014年

An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients.
Hirayuki Enomoto; Nobuhiro Aizawa; Hideji Nakamura; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoko Aoki; Yukihisa Yuri; Kazunori Yoh; Kenji Hashimoto; Akio Ishii; Tomoyuki Takashima; Kazunari Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Gastroenterology research and practice, 2014年

Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen.
Hirayuki Enomoto; Shin-Ichi Inoue; Akio Matsuhisa; Shuhei Nishiguchi
International journal of hepatology, 2014年

Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.
Masaru Enomoto; Shuhei Nishiguchi; Akihiro Tamori; Sawako Kobayashi; Hiroki Sakaguchi; Susumu Shiomi; Soo Ryang Kim; Hirayuki Enomoto; Masaki Saito; Hiroyasu Imanishi; Norifumi Kawada
Journal of gastroenterology, 2013年03月

穿刺針ナビゲーションシステムVirtuTRAX^TM安全使用のための短縮クリップ法
田中 弘教; 池田 直人; 岩田 一也; 高嶋 智之; 楊 和典; 石井 昭生; 坂井 良行; 會澤 信弘; 岩田 恵典; 榎本 平之; 齋藤 正紀; 今西 宏安; 西口 修平; 飯島 尋子
肝臓, 2013年

Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Junko Kato; Tomohiro Okamoto; Hiroyuki Motoyama; Ryosuke Uchiyama; Daniel Kirchhofer; Nico Van Rooijen; Hirayuki Enomoto; Shuhei Nishiguchi; Norifumi Kawada; Jiro Fujimoto; Hiroko Tsutsui
Hepatology (Baltimore, Md.), 2013年01月

Elevation of the AST to ALT ratio in association with the severity of esophageal varices in patients with HCV-related compensated liver cirrhosis.
Yoshinori Iwata; Hirayuki Enomoto; Yoshiyuki Sakai; Nobuhiro Aizawa; Hironori Tanaka; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Kunihiro Hasegawa; Yukihisa Yuri; Kazunari Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko lijima; Shuhei Nishiguchi
Hepato-gastroenterology, 2013年

Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices.
Hirayuki Enomoto; Yoshiyuki Sakai; Nobuhiro Aizawa; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Kunihiro Hasegawa; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Kazunari Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Annals of hepatology, 2013年

Relationship between elevation of glycated albumin to glycated hemoglobin ratio in patients with a high bleeding risk of esophageal varices.
Yoshiyuki Sakai; Hirayuki Enomoto; Nobuhiro Aizawa; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Takashi Iwai; Kazunari Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Hideji Nakamura; Shuhei Nishiguchi
Hepato-gastroenterology, 2012年10月

The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis.
Yukihiro Bando; Hideo Kanehara; Keiko Aoki; Daishy Toya; Kazuo Notsumata; Nobuyoshi Tanaka; Hirayuki Enomoto; Shu-hei Nishiguchi; Keiji Nakasho; Hideji Nakamura; Soji Kasayama; Masafumi Koga
Annals of clinical biochemistry, 2012年07月

Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography.
Hironori Tanaka; Hiroko Iijima; Kazuhiro Nouso; Noriaki Aoki; Takashi Iwai; Tomoyuki Takashima; Yoshiyuki Sakai; Nobuhiro Aizawa; Kazunari Iwata; Naoto Ikeda; Yoshinori Iwata; Hirayuki Enomoto; Masaki Saito; Hiroyasu Imanishi; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2012年04月

Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis.
Nobuhiro Aizawa; Hirayuki Enomoto; Hiroyasu Imanishi; Masaki Saito; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Yoshiyuki Sakai; Tomoyuki Takashima; Takashi Iwai; Ei-Ichiro Moriwaki; Soji Shimomura; Hiroko Iijima; Hideji Nakamura; Shuhei Nishiguchi
World journal of hepatology, 2012年01月

Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis.
Hirayuki Enomoto; Shin-ichi Inoue; Akio Matsuhisa; Nobuhiro Aizawa; Hiroyasu Imanishi; Masaki Saito; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Yoshiyuki Sakai; Tomoyuki Takashima; Soji Shimomura; Hiroko Iijima; Hideji Nakamura; Shuhei Nishiguchi
Journal of hepatology, 2012年01月

Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma.
Soji Shimomura; Naoto Ikeda; Masaki Saito; Akio Ishii; Tomoyuki Takashima; Yoshiyuki Sakai; Shohei Yoshikawa; Nobuhiro Aizawa; Hironori Tanaka; Yoshinori Iwata; Hirayuki Enomoto; Hiroyasu Imanishi; Teruhisa Yamamoto; Hisato Jomura; Hideji Nakamura; Hiroko Iijima; Shuhei Nishiguchi
Hepatology international, 2010年09月

[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
Hirayuki Enomoto; Akio Ishii; Hiroyasu Imanishi; Masaki Saito; Hironori Tanaka; Yoshinori Iwata; Yoshiyuki Sakai; Takashi Iwai; Kazunori Yoh; Tomoyuki Takashima; Shohei Yoshikawa; Nobuhiro Aizawa; Teruhisa Yamamoto; Naoto Ikeda; Soji Shimomura; Hiroko Iijima; Seiichi Hirota; Shuhei Nishiguchi
Gan to kagaku ryoho. Cancer & chemotherapy, 2010年05月

自己免疫性肝炎に発症した肝細胞癌にUFT-E投与が有効であった1例
榎本 平之; 今西 宏安
癌と化学療法, 2010年, ［査読有り］

Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells.
Ke Cao; Weidong Liu; Hideji Nakamura; Hirayuki Enomoto; Teruhisa Yamamoto; Masaki Saito; Hiroyasu Imanishi; Soji Shimomura; Peiguo Cao; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2009年11月

Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice.
Hirayuki Enomoto; Hideji Nakamura; Naoko Komatsu-Kanatani; Yu Liu; Kenya Yoshida; Yorihide Okuda; Teruhisa Yamamoto; Weidong Liu; Shuhei Nishiguchi
World journal of hepatology, 2009年10月

Hepatoma-derived growth factor is induced in liver regeneration.
Hirayuki Enomoto; Hideji Nakamura; Weidong Liu; Kenya Yoshida; Yorihide Okuda; Hiroyasu Imanishi; Masaki Saito; Soji Shimomura; Toshikazu Hada; Shuhei Nishiguchi
Hepatology research : the official journal of the Japan Society of Hepatology, 2009年10月

Ｓｏｎａｚｏｉｄ造影超音波による新しい肝癌悪性度分類法の試み
田中 弘教; 飯島 尋子; 齋藤 正紀; 會澤 信弘; 坂井 良行; 吉川 昌平; 山本 晃久; 榎本 平之; 岩田 恵典; 康 典利; 今西 宏安; 下村 壯治; 中村 秀次; 廣田 誠一; 辻村 亨; 藤元 治朗; 西口 修平
肝臓, 2009年

Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).
Teruhisa Yamamoto; Hideji Nakamura; Weidong Liu; Ke Cao; Shohei Yoshikawa; Hirayuki Enomoto; Yoshinori Iwata; Noritoshi Koh; Masaki Saito; Hiroyasu Imanishi; Soji Shimomura; Hiroko Iijima; Toshikazu Hada; Shuhei Nishiguchi
Journal of gastroenterology, 2009年

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C.
Hirokazu Uyama; Hideji Nakamura; Eijiro Hayashi; Hiroyuki Ogawa; Hirayuki Enomoto; Kenya Yoshida; Yorihide Okuda; Mitsunari Yamamoto; Toshikazu Hada; Norio Hayashi
Hepatology research : the official journal of the Japan Society of Hepatology, 2007年05月

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Hirokazu Uyama; Yasuhiko Tomita; Hideji Nakamura; Shoji Nakamori; Binglin Zhang; Yoshihiko Hoshida; Hirayuki Enomoto; Yorihide Okuda; Masato Sakon; Katsuyuki Aozasa; Ichiro Kawase; Norio Hayashi; Morito Monden
Clinical cancer research : an official journal of the American Association for Cancer Research, 2006年10月

Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Kenya Yoshida; Yasuhiko Tomita; Yorihide Okuda; Shinji Yamamoto; Hirayuki Enomoto; Hirokazu Uyama; Hiroaki Ito; Yoshihiko Hoshida; Katsuyuki Aozasa; Hiroaki Nagano; Masato Sakon; Ichiro Kawase; Morito Monden; Hideji Nakamura
Annals of surgical oncology, 2006年02月

[Palliation of malignant bile duct obstruction with metallic stent-clinical effectiveness in aged patients].
Makoto Fujita; Noriyuki Takeuchi; Masato Sakon; Takahiro Niinobu; Naozumi Higaki; Hiroto Hayashida; Masahiro Amano; Yasuaki Nishikawa; Sumiko Nakagawa; Yutaka Itani; Hiroyuki Ogawa; Hiroyuki Oohata; Hirayuki Enomoto; Kenya Yoshida
Gan to kagaku ryoho. Cancer & chemotherapy, 2005年10月

Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.
Takashi Fujita; Ryo Fukuyama; Hirayuki Enomoto; Toshihisa Komori
Journal of cellular biochemistry, 2004年10月

Runx2 deficiency in chondrocytes causes adipogenic changes in vitro.
Hirayuki Enomoto; Tatsuya Furuichi; Akira Zanma; Kei Yamana; Carolina Yoshida; Satoru Sumitani; Hiroyasu Yamamoto; Motomi Enomoto-Iwamoto; Masahiro Iwamoto; Toshihisa Komori
Journal of cell science, 2004年01月

Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
Hideji Nahamura; Kenya Yoshida; Yoshihiko Kishima; Hirayuki Enomoto; Hirokazu Uyama; Toshifumi Kuroda; Yorihide Okuda; Tomonori Hirotani; Hiroaki Ito; Ichiro Kawase
Hepato-gastroenterology, 2004年

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.
Yorihide Okuda; Hideji Nakamura; Kenya Yoshida; Hirayuki Enomoto; Hirokazu Uyama; Tomonori Hirotani; Masanobu Funamoto; Hiroaki Ito; Allen D Everett; Toshikazu Hada; Ichiro Kawase
Cancer science, 2003年12月

Expression of hepatoma-derived growth factor in hepatocarcinogenesis.
Kenya Yoshida; Hideji Nakamura; Yorihide Okuda; Hirayuki Enomoto; Yoshihiko Kishima; Hirokazu Uyama; Hiroaki Ito; Tsutomu Hirasawa; Shuichiro Inagaki; Ichiro Kawase
Journal of gastroenterology and hepatology, 2003年11月

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
Hirayuki Enomoto; Satoko Shiojiri; Kazuto Hoshi; Tatsuya Furuichi; Ryo Fukuyama; Carolina A Yoshida; Naoko Kanatani; Reiko Nakamura; Atsuko Mizuno; Akira Zanma; Kazuki Yano; Hisataka Yasuda; Kanji Higashio; Kenji Takada; Toshihisa Komori
The Journal of biological chemistry, 2003年06月

The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C.
Hideji Nakamura; Hirokazu Uyama; Hirayuki Enomoto; Yoshihiko Kishima; Mitsunari Yamamoto; Kenya Yoshida; Yorihide Okuda; Tomonori Hirotani; Toshifumi Kuroda; Hiroaki Ito; Masahiro Matsuda; Minoru Terabayashi; Sanai Noguchi
Hepato-gastroenterology, 2003年

A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
Hirokazu Uyama; Hirayuki Enomoto; Yoshihiko Kishima; Mitsunari Yamamoto; Kenya Yoshida; Yorihide Okuda; Tomonori Hirotani; Toshifumi Kuroda; Hiroaki Ito; Masahiro Matsuda; Minoru Terabayashi; Sanai Noguchi; Ichiro Kawase; Hideji Nakamura
Hepato-gastroenterology, 2003年

Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.
Hirayuki Enomoto; Kenya Yoshida; Yoshihiko Kishima; Taisei Kinoshita; Mitsunari Yamamoto; Allen D Everett; Atsushi Miyajima; Hideji Nakamura
Hepatology (Baltimore, Md.), 2002年12月

Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis.
Hideji Nakamura; Kenya Yoshida; Kazuhiro Ikegame; Yoshihiko Kishima; Hirokazu Uyama; Hirayuki Enomoto
Journal of gastroenterology, 2002年11月

Participation of hepatoma-derived growth factor in the regulation of fetal hepatocyte proliferation.
Hirayuki Enomoto; Kenya Yoshida; Yoshihiko Kishima; Yorihide Okuda; Hideji Nakamura
Journal of gastroenterology, 2002年11月

Impaired vascular invasion of Cbfa1-deficient cartilage engrafted in the spleen.
Miki Himeno; Hirayuki Enomoto; Wenguang Liu; Kiyoto Ishizeki; Shintaro Nomura; Yukihiko Kitamura; Toshihisa Komori
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2002年07月

Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals.
Yoshihiko Kishima; Hiroyasu Yamamoto; Yoshitaka Izumoto; Kenya Yoshida; Hirayuki Enomoto; Mitsunari Yamamoto; Toshifumi Kuroda; Hiroaki Ito; Kazuyuki Yoshizaki; Hideji Nakamura
The Journal of biological chemistry, 2002年03月

Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
Hideji Nakamura; Hiyoyuki Ogawa; Toshifumi Kuroda; Mitsunari Yamamoto; Hirayuki Enomoto; Yoshihiko Kishima; Kenya Yoshida; Hiroaki Ito; Masahiro Matsuda; Sanai Noguchi
Hepato-gastroenterology, 2002年

Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
Yoshihiko Kishima; Kenya Yoshida; Hirayuki Enomoto; Mitsunari Yamamoto; Toshifumi Kuroda; Yorihide Okuda; Hirokazu Uyama; Hideji Nakamura
Hepato-gastroenterology, 2002年

Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes
Chisato Ueta; Masahiro Iwamoto; Naoko Kanatani; Carolina Yoshida; Yang Liu; Motomi Enomoto-Iwamoto; Tomoharu Ohmori; Hirayuki Enomoto; Ken Nakata; Kenji Takada; Kojiro Kurisu; Toshihisa Komori
Journal of Cell Biology, 2001年04月

Participation of Cbfa1 in regulation of chondrocyte maturation
M. Enomoto-Iwamoto; H. Enomoto; T. Komori; M. Iwamoto
Osteoarthritis and Cartilage, 2001年

Intestinal Behçet's disease associated with myelodysplastic syndrome with chromosomal trisomy 8 - A report of two cases and a review of the literature
H. Ogawa; T. Kuroda; M. Inada; M. Yamamoto; H. Enomoto; Y. Kishima; K. Yoshida; H. Ito; H. Ogawa; H. Nakamura
Hepato-Gastroenterology, 2001年

Cbfa1 is a positive regulatory factor in chondrocyte maturation
Hirayuki Enomoto; Motomi Enomoto-Iwamoto; Masahiro Iwamoto; Shintaro Nomura; Miki Himeno; Yukihiko Kitamura; Tadamitsu Kishimoto; Toshihisa Komori
Journal of Biological Chemistry, 2000年03月

Forced expression of terminal deoxynucleotidyl transferase in fetal thymus resulted in a decrease in γδ T cells and random dissemination of Vγ3Vδ1 T cells in skin of newborn but not adult mice
A. Aono; H. Enomoto; N. Yoshida; K. Yoshizaki; T. Kishimoto; Toshihisa Komori
Immunology, 2000年

Protein kinase C inhibitor, H-7 suppresses the growth activity of hepatoma-derived growth factor
H. Kambe; Y. Kishima; T. Kuroda; H. Enomoto; H. Ogawa; H. Nakamaura
Hepato-Gastroenterology, 2000年

A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus
Kazuhiro Ikegame; Mitsunari Yamamoto; Yoshihiko Kishima; Hirayuki Enomoto; Kenya Yoshida; Masaki Suemura; Tadamitsu Kishimoto; Hideji Nakamura
Biochemical and Biophysical Research Communications, 1999年12月

Initial daily interferon administration can gain more eradication of HCV-RNA in patients with chronic hepatitis C, especially with serum intermediate viral load
Hideji Nakamura; Hiroaki Ito; Hiroyuki Ogawa; Akira Takeda; Sumie Kanazawa; Toshifumi Kuroda; Mitsunari Yamamoto; Hirayuki Enomoto; Yoshihiro Kimura; Sadao Zenda; Minoru Terabayashi; Kou Saeki; Sanai Noguchi; Hideki Hara; Masanao Uemiya; Atsushi Igarashi; Eijiro Hayashi
Hepato-Gastroenterology, 1999年

特集 肝疾患-診療のチェックポイント2023 第Ⅰ部 診断のチェックポイント 第4章 肝画像診断のチェックポイント 1.肝障害患者のエコーによる肝疾患画像
西村 貴士; 吉田 昌弘; 東浦 晶子; 榎本 平之; 飯島 尋子
臨床消化器内科, 2023年06月09日

特集 ウイルス肝炎制御時代の肝発癌 1.ウイルス肝炎制御をめぐる疫学と最新動向(4)わが国における肝硬変成因の動向
榎本 平之; 飯島 尋子
臨床消化器内科, 2022年07月20日

疫学 自己免疫性肝疾患の疫学—Epidemiology of the autoimmune liver diseases—特集 自己免疫性肝疾患 : 自己免疫性肝炎,原発性胆汁性胆管炎,原発性硬化性胆管炎
榎本 平之; 西口 修平
日本臨床 = Japanese journal of clinical medicine, 2020年01月

サルコペニアの定義・診断基準—Definition and diagnostic criteria of sarcopenia—特集 肝疾患におけるサルコペニア
西口 修平; 西川 浩樹; 榎本 平之
消化器・肝臓内科 = Gastroenterology & hepatology / 消化器・肝臓内科編集委員会 編, 2019年01月

超高齢化時代の肝臓診療オーバービュー—Overview of Clinical aspects for the super aged patients with liver disease—特集 超高齢者の肝臓診療
西口 修平; 高嶋 智之; 榎本 平之
消化器・肝臓内科 = Gastroenterology & hepatology / 消化器・肝臓内科編集委員会 編, 2018年10月

4）肝疾患とサルコペニア
西口 修平; 榎本 平之; 西川 浩樹
日本内科学会雑誌, 2018年09月10日

Meeting Report 第54回日本肝臓学会総会
榎本 平之
The liver cancer journal = ザリバーキャンサージャーナル : 季刊学術雑誌 / 「The liver cancer journal」編集委員会 編, 2018年09月

肝性浮腫・腹水に対するアルブミン投与は有用である(保険診療の現状も含めて)—肝不全 : その常識は正しいか? ; 慢性肝不全 : その常識は正しいか?
坂井 良行; 榎本 平之; 西口 修平
救急・集中治療, 2016年

肝疾患患者の診療の進め方—Process of medical treatment for liver diseases—特集 肝疾患診療の新展開
榎本 平之; 西口 修平
日本医師会雑誌 = The Journal of the Japan Medical Association, 2015年10月

Meeting Report 第51回日本肝臓学会総会
榎本 平之
The liver cancer journal = ザリバーキャンサージャーナル : 季刊学術雑誌 / 「The liver cancer journal」編集委員会 編, 2015年09月

PEG-IFN/IFN単独療法—PEG-IFN/IFN monotherapy—特集 C型肝炎治療update : 基礎・臨床研究の最新知見 ; 治療
榎本 平之; 西口 修平
日本臨床 = Japanese journal of clinical medicine, 2015年02月

特発性細菌性腹膜炎診断におけるin-situ hybridizationの有用性—Usefulness of the in-situ hybridization method for the diagnosis of spontaneous bacterial peritonitis—特集 非代償性肝硬変の合併症と予後
榎本 平之; 井上 慎一; 松久 明生
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2014年09月

C型肝炎のすべて (第IV章)C型肝炎からの肝発癌の制御 抗ウイルス療法による肝癌発生の抑制
西口 修平; 榎本 平之
臨床消化器内科, 2014年05月25日

ウイルス肝炎診療の最前線と今後の展開 日常臨床のポイントと知っておきたい最新情報 ウイルス肝炎における日常診療のポイント ウイルス性慢性肝炎肝硬変における日常管理のポイント
榎本 平之; 西口 修平
内科, 2014年04月01日

血小板低値C型慢性肝疾患のIFN療法における脾摘・PSEの適応基準—Adaptation of splenectomy and partial splenic embolization before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia—特集 C型肝炎治療困難例への対策
会澤 信弘; 榎本 平之; 西口 修平
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2014年03月

血小板低値・C型慢性肝疾患のIFN療法における脾摘･PSEの適応基準—Adaptation of splenectomy and partial splenic embolization before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia—特集 肝疾患の病態に及ぼす血小板の意義
会澤 信弘; 楊 和典; 榎本 平之
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2013年08月

インターフェロン治療の難治性に関与する宿主囚子:抗インターフェロン中和抗体について—Involvement of anti-interferon-α neutralizing antibody in non-response to pegylated interferon-α plus ribavirin therapy in chronic hepatitis C—特集 C型慢性肝炎の新たな治療展開
榎本 平之; 松田 二子; 西口 修平
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2013年04月

腹水・浮腫を伴う肝硬変患者のマネジメント—特集 肝疾患up to date : プライマリ・ケアで押さえておきたい最新トピックス ; 肝硬変に関するトピックス
榎本 平之; 西口 修平
治療, 2012年09月

血小板低値のC型慢性肝疾患症例におけるインターフェロン治療—Interferon treatment for patients with chronic hepatitis C and thrombocytopenia—特集 C型肝炎個別化医療のための宿主因子,ウイルス因子
榎本 平之; 池田 直人; 会澤 信弘
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2012年08月

C型慢性肝炎組織に生じるミトコンドリア遺伝子異常と発癌—Relationship between the mitochondria gene abnormality in liver tissues and hepatocarcinogenesis in patients with chronic viral hepatitis C—特集 炎症と消化器癌
会澤 信弘; 高嶋 智之; 榎本 平之
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2012年06月

C型肝硬変に対するPEG-IFN/RBV併用療法の治療成績—Pegylated interferon and ribavirin combination therapy for HCV-related cirrhosis—特集 C型肝炎治療の新たな展開
会澤 信弘; 高島 智之; 榎本 平之
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2012年04月

合併症対策 腹水の治療と特発性細菌性腹膜炎に対する新規診断法 : "菌のみえない"感染症へのアプローチ—Treatment of ascites and a new diagnosis method for spontaneous bacterial peritonitis—第1土曜特集 肝硬変Update : 肝硬変死の根絶をめざして
榎本 平之; 西口 修平
医学のあゆみ, 2012年03月03日

C型慢性肝炎におけるミトコンドリア遺伝子異常とインスリン抵抗性—Relationship between the mitochondria gene abnormality in liver tissues and the insulin resistance in patients with chronic viral hepatitis C—特集 肝発癌・進展とインスリン抵抗性
会澤 信弘; 岩田 一也; 榎本 平之
消化器内科 = Gastroenterology / 消化器内科編集委員会 編, 2011年03月

内科疾患の診断基準 病型分類･重症度 肝胆膵 慢性肝炎
榎本 平之; 坂井 良行; 会澤 信弘; 西口 修平
内科, 2010年06月01日

Ａｃｏｕｓｔｉｃ Ｒａｄｉａｔｉｏｎ Ｆｏｒｃｅ Ｉｍｐｕｌｓｅによる非侵襲的肝線維化診断法の有用性
飯島 尋子; 田中 弘教; 吉田 昌弘; 池田 直人; 山本 晃久; 岩田 恵典; 榎本 平之; 齋藤 正紀; 今西 宏安; 下村 壯治; 中正 恵二; 廣田 誠一; 辻村 亨; 西口 修平
肝臓, 2010年

肝庇護療法 ビタミンK2—Growth inhibition of hepatoma cells by vitamin K2—肝癌--基礎・臨床研究のアップデート ; 肝発癌予防・再発予防
榎本 平之; 山本 晃久; 劉 衛東
日本臨床 = Japanese journal of clinical medicine, 2009年05月

肝細胞癌の増殖におけるHDGF(Hepatoma-derived growth factor)の役割
榎本 平之; 今西 宏安
消化器疾患におけるエピゲノミクスとゲノミクス, 2009年

胎生期未分化肝細胞の増殖におけるHDGF (Hepatoma-derived growth factor)の役割.消化器疾患におけるTranslational Research
榎本 平之; 中村 秀次; 今西 宏安
アークメディア, 2008年

診断ピットフォール 症例から学ぶ 検査値 LDHの異常 腹部臓器以外の疾患でも心窩部痛を訴えることがある
榎本 平之; 西口 修平
内科, 2007年06月01日

診断ピットフォール 症例から学ぶ 検査値 LDHの異常 消化器症状を伴う貧血でも消化管出血とは限らない
榎本 平之; 西口 修平
内科, 2007年06月01日

肝硬変患者におけるアルブミン代謝について
榎本 平之; 西口 修平
日本門脈圧亢進症学会雑誌, 2006年

肝細胞癌の再発、生命予後を予測する分子腫瘍マーカーとしてのHDGFの有用性
中村 秀次; 吉田 賢哉; 富田 裕彦; 山本 慎治; 山元 哲雄; 奥田 偉秀; 榎本 平之; 伊藤 裕章; 川瀬 一郎; 青笹 克之; 永野 浩明; 左近 賢人; 門田 守人; 波田 壽一
日本分子腫瘍マーカー研究会誌, 2003年

Hepatoma-derived growth factor (HDGF) and HDGF family
H. Nakamura; H. Enomoto; Y. Kishima; K. Yoshida; T. Kuroda
Nippon rinsho. Japanese journal of clinical medicine, 2001年10月

Cbfa1と軟骨分化—特集 関節疾患の分子医学--基礎と臨床 ; 基礎
榎本 平之; 小守 壽文
現代医療, 2001年

Cbfa1は軟骨分化促進因子である
榎本 平之; 岩本 資巳; 岩本 容泰; 野村 慎太郎; 小守 壽文
日本骨代謝学会雑誌 = Japanese journal of bone metabolism, 1999年06月26日

核酸医薬を応用した肝癌由来増殖因子を標的とする新たな肝細胞癌治療薬の開発
基盤研究(C)
兵庫医科大学
2021年04月01日 - 2024年03月31日

Apop-1を標的とした脂肪肝や肝癌の発症機構とミトコンドリア機能との関係の解明
基盤研究(B)
武庫川女子大学
2021年04月01日 - 2024年03月31日

肝癌由来増殖因子とヌクレオリンの機能解析による新たな肝癌治療の開発
基盤研究(C)
兵庫医科大学
2016年04月01日 - 2020年03月31日

慢性肝疾患における肝細胞障害と肝内凝固亢進状態の関連性に関する検討
基盤研究(C)
兵庫医科大学
2013年04月01日 - 2016年03月31日

肝癌由来増殖因子の血管新生と肝癌増殖における役割の検討
基盤研究(C)
兵庫医科大学
2012年04月01日 - 2016年03月31日

肝癌由来増殖因子の発現制御およびシグナル伝達調節による肝癌増殖制御法の開発
基盤研究(C)
兵庫医科大学
2009年 - 2011年

肝癌由来増殖因子と受容体の発現・活性化調節による肝癌増殖の制御
基盤研究(C)
兵庫医科大学
2007年 - 2008年